drugset / Trial / NCT06915688

A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations

NCT06915688

Not yet recruiting 188 enrolled Amina Aslam
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will include patients with chronic obstructive pulmonary disease (COPD) who present with an acute exacerbation. Participants will be randomly assigned to receive either doxycycline or levofloxacin for 5 days. The aim is to compare how effective each antibiotic is in improving symptoms after 2 days of treatment.

Timeline

Start
2025-04-15
Primary completion
2025-07-28
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline Small molecule 100 mg
Comparator Levofloxacin Small molecule 500 mg